The Valley Desk

NCT07287982 · Interventional trial

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Overall registry status Recruiting

Phase 2

Conditions Spinal Muscular Atrophy (SMA)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov